Abstract
Transient restricted diffusion and increased T2 signal intensity within the splenium of the corpus callosum is an increasingly recognized albeit uncommon imaging feature in the setting of acute encephalitis and antecedent viral illness. This review will discuss three index cases obtained from an institutional databank. Additionally, the current understanding of the underlying neurophysiologic pathogenesis will be discussed together with differential clinical and imaging diagnostic considerations, treatment options, and outcome metrics.
References
Kim SS, Chang K-H, Kim ST et al (1999) Focal lesion in the splenium of the corpus callosum in epileptic patients: antiepileptic drug toxicity? AJNR 20:125–129
Polster T, Hoppe M, Ebner A (2001) Transient lesion in the splenium of the corpus callosum: three further cases in epileptic patients and a pathophysiological hypothesis. J Neurol Neurosurg Psychiatry 70:459–463
Maeda M, Shiroyama T, Tsukahara H et al (2003) Transient splenial lesion of the corpus callosum associated with antiepileptic drugs: evaluation by diffusion-weighted MR imaging. Eur Radiol 13:1902–1906
Takanashi J, Barkovich A, Yamaguchi K et al (2004) Influenza encephalopathy with a reversible lesion in the splenium of the corpus callosum. AJNR 25:798–802
Kobata R, Tsukahara H, Nakai A et al (2002) Transient MR signal changes in the splenium of the corpus callosum in rotavirus encephalopathy: value of diffusion-weighted imaging. J Comput Assist Tomogr 26:825–828
Tada H, Takanashi J, Barkovich A et al (2004) Clinically mild encephalitis/encephalopathy with a reversible splenial lesion. Neurology 63:1854–1858
Kashiwagi M, Tanabe T, Shimakawa S et al (2014) Clinico-radiologic spectrum of reversible splenial lesions in children. Brain Dev 36:330–336
Pan J, Zhao Y, Lu C et al (2015) Mild encephalitis/encephalopathy with a reversible splenial lesion: five cases and a literature review. Neurol Sci 36:2043–2051
Garcia-Monco J, Cortina I, Martinez A et al (2011) Reversible splenial lesion syndrome (RESLES): what’s in a name? J Neuroimaging 21(2):e1–14
Takanashi J, Barkovich A, Shihara T et al (2006) Widening spectrum of a reversible splenial lesion with transient reduced diffusion. AJNR 27:836–838
Hagemenn G, Mentzel H, Weisser H et al (2006) Multiple reversible MR signal changes caused by Epstein-Barr virus encephalitis. AJNR 27:1447–1449
Bulakbasi N, Kocaoglu M, Tayfun C et al (2006) Transient splenial lesion of the corpus callosum in clinically mild influenza-associated encephalitis/encephalopathy. AJNR 27:1983–1986
Maeda M, Tsukahara H, Terada H et al (2006) Reversible splenial lesion with restricted diffusion in a wide spectrum of diseases and conditions. J Neuroradiol 33(4):229–236
Tha K, Terae S, Sugiura M et al (2002) Diffusion-weighted magnetic resonance imaging in early stage of 5-flourouracil-induced leukoencephalopathy. Acta Neuro Scand 106(6):379–386
Cecil K, Halsted M, Schapiro M et al (2002) Reversible MR imaging and MR spectroscopy abnormalities in association with metronidazole therapy. J Comput Assit Tomogr 26(6):948–951
Takayama H, Kobayashi M, Sugishita M et al (2000) Diffusion-weighted imaging demonstrates transient cytotoxic edema involving the corpus callosum in a patient with diffuse brain injury. Clin Neurol Neurosurg 102(3):135–139
Matsusue E, Kinoshita T, Ohama E et al (2005) Cerebral cortical and white matter lesions in chronic hepatic encephalopathy: MR-pathologic correlations. AJNR 26(2):347–351
Rovira A, Alonso J, Cordoba J (2008) MR imaging findings in hepatic encephalopathy. AJNR 29(9):1612–1621
Kim J, Choi J, Koh S et al (2007) Reversible splenial abnormality in hypoglycemic encephalopathy. Neuroradiology 49(3):217–222
Starkey J, Kobayashi N, Numagachi Y et al (2017) Cytotoxic lesions of the corpus callosum that show restricted diffusion: mechanisms, causes and manifestations. Radiographics 37:562–576
Gallucci M, Limbucci N, Paonessa A et al (2007) Reversible focal splenial lesions. Neuroradiology 49:541–544
Moritani T, Smoker WR, Sato Y et al (2005) Diffusion-weighted imaging of acute excitotoxic brain injury. AJNR 26:216–228
Mark LP, Prost RW, Ulmer JL et al (2001) Pictorial review of glutamate excitotoxicity: fundamental concepts for neuroimaging. AJNR 22:1813–1824
Jeong T, Yoon J, Lee J et al (2015) Reversible splenial lesion syndrome (RESLES) following glufosinate ammonium poisoning. J Neuroimag 25:1050–1052
daRocha A, Reis F, Gama H et al (2006) Focal transient lesion in the splenium of the corpus callosum in three non-epileptic patients. Neuroradiology 48:731–735
Notebaert A, Willems J, Coucke L et al (2013) Expanding the spectrum of MERS type 2 lesions, a particular form of encephalitis. Ped Neurology 48(2):135–138
Cho J, Ha S, Han Y et al (2007) Mild encephalopathy with reversible lesion in the splenium of the corpus callosum and bifrontal white matter. J Clin Neurol 3:53–56
Zhu Y, Zheng J, Zhang L et al (2016) Reversible splenial lesion syndrome associated with encephalitis/encephalopathy presenting with great clinical heterogeneity. BMC Neurol 16:49
Takanashi J, Imamura A, Hayakawa F et al (2010) Differences in the time course of splenial and white matter lesions in clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS). J Neurol Sci 292(1–2):24–27
Ueda N, Minami S, Akimoto M (2016) Mycoplasma pneumoniae-associated mild encephalitis/encephalopathy with a reversible splenial lesion: report of two pediatric cases and a comprehensive literature review. BMC Infec Dis 16:671
Chen W, Liu H, Yang S et al (2016) Reversible splenial lesion syndrome in children: retrospective study and summary of case series. Brain and Development 38(10):915–927
Melenotte C, Craighero F, Girard N et al (2013) Measles encephalitis the return: mild encephalitis with reversible splenial lesion. Int J Infec Dis 17(1):72–73
Abenhaim Halpern L, Agyeman P et al (2013) Mild encephalopathy with splenial lesion and parainfluenza virus infection. Pediatr Neurol 48:252–254
Fay AJ, Noetzel MJ, Mar SS (2015) Pediatric hemorrhagic brainstem encephalitis associated with HHV-7 infection. Pediatr Neurol 53:523–526
Suzuki H, Kusaka T, Okada H (2014) Clinically mild encephalitis/encephalopathy with a reversible splenial lesion caused by human parvovirus b19 infection: a case of two brothers with hereditary spherocytosis. Pediatr Neurol 51:470–472
Hasegawa S, Matsushige T, Inoue H et al (2011) Serum and cerebrospinal fluid cytokine profile of patients with 2009 pandemic H1N1 influenza virus-associated encephalopathy. Cytokine 54:167–172
Hoshino A, Saitoh M, Oka A et al (2012) Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes. Brain and Development 34:337–343
Ka A, Britton P, Troedson C et al (2015) Mild encephalopathy with reversible splenial lesion: an important differential of encephalitis. Eur J Paediatr Neurol 19:377–382
Karampatsas K, Spyridou C, Morrison I et al (2015) Rotavirus-associated mild encephalopathy with a reversible splenial lesion (MERS)—case report and review of the literature. BMC Infec Dis 15:446
Takanashi J (2009) Two newly proposed infectious encephalitis/encephalopathy syndromes. Brain and Development 31:521–528
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Lin, D., Rheinboldt, M. Reversible splenial lesions presenting in conjunction with febrile illness: a case series and literature review. Emerg Radiol 24, 599–604 (2017). https://doi.org/10.1007/s10140-017-1516-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10140-017-1516-4